Mutational Analysis of Clonality in Multiple Primary Melanoma

多原发性黑色素瘤克隆性的突变分析

基本信息

  • 批准号:
    7291557
  • 负责人:
  • 金额:
    $ 6.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-30 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Melanoma patients are very frequently diagnosed with putative second primaries. Indeed, some patients experience multiple occurrences of the disease. While these phenomena could be explained by strong genetic predisposition, it is also possible that a significant subset of these second and higher-order primaries are actually (clonal) recurrences of the initial primary, since many studies in other sites have occasionally confirmed a clonal origin for new tumors that are presumed to be independent on the basis of classical pathological criteria. Accurate classification of subsequent primaries has important clinical implications, but it is also of considerable relevance for epidemiologic research, since patients with multiple primaries are increasingly being recognized as an important resource, especially for studies of rare genetic factors. Our goal in this study is to conduct a pilot clonality investigation in patients diagnosed with double primary melanoma. Specifically, in order to identify molecular differences and similarities between tumors we propose to: (1) compare the mutational profiles of pairs of primary melanomas from individual patients with double malignancies using micro-satellite instability markers; and (2) reproduce the strategy in Aim 1 using array CGH rather than candidate markers. We will test 25 sets of first and second primary lesions from individuals diagnosed with double primary melanoma. This study will be the first to assess evidence for clonality in multiple primary melanoma. Our results will have implications for the pathologic classification of melanoma, clinical decision making for a patient with a second primary, and epidemiologic research methods. If results from this study suggest that cutaneous metastases are frequently diagnosed as second malignancies, then we will plan a subsequent study using the large population-based resource of tumor tissues from patients with double primary melanoma collected from the international population-based GEM Study (CA83180), designed to determine definitively the frequency of mis-diagnosis, and to determine predictors of tumors that would benefit from mutational profiling to validate the diagnosis.
描述(由申请人提供): 黑色素瘤患者经常被诊断为第二原发性黑色素瘤。事实上,一些患者经历了该疾病的多次发生。虽然这些现象可以用强遗传倾向来解释,但也有可能这些第二和更高阶原发灶的重要子集实际上是初始原发灶的(克隆)复发,因为其他研究中心的许多研究偶尔证实了新肿瘤的克隆起源,这些肿瘤被认为是独立于经典病理学标准的。随后原发灶的准确分类具有重要的临床意义,但它也与流行病学研究相当相关,因为患有多原发灶的患者越来越被认为是一种重要的资源,特别是对于罕见遗传因素的研究。本研究的目的是对诊断为双原发性黑色素瘤的患者进行初步克隆性研究。具体而言,为了鉴定肿瘤之间的分子差异和相似性,我们提出:(1)使用微卫星不稳定性标记物比较来自患有双重恶性肿瘤的个体患者的成对原发性黑素瘤的突变谱;以及(2)使用阵列CGH而不是候选标记物再现目标1中的策略。我们将测试25组来自诊断为双原发性黑色素瘤的个体的第一和第二原发性病变。这项研究将是第一个评估多原发性黑色素瘤克隆性的证据。我们的研究结果将对黑色素瘤的病理分类、第二原发性黑色素瘤患者的临床决策和流行病学研究方法产生影响。如果本研究的结果表明皮肤转移经常被诊断为继发性恶性肿瘤,则我们将计划使用从基于国际人群的GEM研究(CA 83180)中收集的双原发性黑色素瘤患者的大规模基于人群的肿瘤组织资源进行后续研究,旨在明确确定误诊的频率,并确定肿瘤的预测因子,这些预测因子将受益于突变谱分析以验证诊断。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.
  • DOI:
    10.1002/sim.3866
  • 发表时间:
    2010-07-10
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Ostrovnaya, Irina;Olshen, Adam B.;Seshan, Venkatraman E.;Orlow, Irene;Albertson, Donna G.;Begg, Colin B.
  • 通讯作者:
    Begg, Colin B.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IRENE ORLOW其他文献

IRENE ORLOW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IRENE ORLOW', 18)}}的其他基金

Validation of the use of whole-genome amplified DNA in a population-based study
验证全基因组扩增 DNA 在基于人群的研究中的使用
  • 批准号:
    8445608
  • 财政年份:
    2013
  • 资助金额:
    $ 6.29万
  • 项目类别:
Validation of the use of whole-genome amplified DNA in a population-based study
验证全基因组扩增 DNA 在基于人群的研究中的使用
  • 批准号:
    8601920
  • 财政年份:
    2013
  • 资助金额:
    $ 6.29万
  • 项目类别:
Mutational Analysis of Clonality in Multiple Primary Melanoma
多原发性黑色素瘤克隆性的突变分析
  • 批准号:
    7214248
  • 财政年份:
    2006
  • 资助金额:
    $ 6.29万
  • 项目类别:

相似海外基金

A human slice model to understand the role of fibrosis in children with bladder exstrophy
人体切片模型了解纤维化在膀胱外翻儿童中的作用
  • 批准号:
    MR/X030946/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.29万
  • 项目类别:
    Research Grant
Development of a comprehensive microbial immunotherapy platform with immuno-transcriptomic monitoring for treatment of bladder cancer (DOCMI-BC)
开发用于治疗膀胱癌的具有免疫转录组监测的综合微生物免疫治疗平台(DOCMI-BC)
  • 批准号:
    10087336
  • 财政年份:
    2024
  • 资助金额:
    $ 6.29万
  • 项目类别:
    Collaborative R&D
BBconnect - a people-centred, system aware design feasibility investigation that aims to define innovation opportunities, generate and evaluate viable ideas for more accessible, effective and integrated bladder and bowel healthcare services.
BBconnect - 一项以人为本、系统意识的设计可行性调查,旨在定义创新机会,生成和评估可行的想法,以提供更方便、有效和综合的膀胱和肠道医疗保健服务。
  • 批准号:
    10089501
  • 财政年份:
    2023
  • 资助金额:
    $ 6.29万
  • 项目类别:
    Collaborative R&D
NIMBLE - an artificial intelligence-based early warning system for bladder cancer
NIMBLE——基于人工智能的膀胱癌早期预警系统
  • 批准号:
    486937
  • 财政年份:
    2023
  • 资助金额:
    $ 6.29万
  • 项目类别:
    Miscellaneous Programs
Early life bladder inflammatory events in female mice lead to subsequent LUTS in adulthood
雌性小鼠生命早期的膀胱炎症事件导致成年后的 LUTS
  • 批准号:
    10638866
  • 财政年份:
    2023
  • 资助金额:
    $ 6.29万
  • 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
  • 批准号:
    10674401
  • 财政年份:
    2023
  • 资助金额:
    $ 6.29万
  • 项目类别:
A Robotic System to Remove Bladder Tumors Intact: The Key to Making Lifesaving Treatment Decisions
完整切除膀胱肿瘤的机器人系统:做出救生治疗决策的关键
  • 批准号:
    10760853
  • 财政年份:
    2023
  • 资助金额:
    $ 6.29万
  • 项目类别:
Mechanistic-Based Treatment of Interstitial Cystitis/Bladder Pain Syndrome
间质性膀胱炎/膀胱疼痛综合征的机械治疗
  • 批准号:
    10659814
  • 财政年份:
    2023
  • 资助金额:
    $ 6.29万
  • 项目类别:
Investigating mechanisms of bladder cancer metastasis
研究膀胱癌转移的机制
  • 批准号:
    10718278
  • 财政年份:
    2023
  • 资助金额:
    $ 6.29万
  • 项目类别:
Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
用尿液检测代替侵入性膀胱镜检查进行非肌肉侵入性膀胱癌监测
  • 批准号:
    10559724
  • 财政年份:
    2023
  • 资助金额:
    $ 6.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了